CN Patent

CN101754972A — Sglt2抑制剂的晶体结构及其制备方法

Assigned to Bristol Myers Squibb Co · Expires 2010-06-23 · 16y expired

What this patent protects

本发明涉及式(I)化合物的呈H-1型、H-2型或S-PG型的物理晶体结构，包含化合物I的结构的药物组合物，以及用化合物I治疗疾病的方法。

USPTO Abstract

本发明涉及式(I)化合物的呈H-1型、H-2型或S-PG型的物理晶体结构，包含化合物I的结构的药物组合物，以及用化合物I治疗疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101754972A
Jurisdiction
CN
Classification
—
Expires
2010-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.